The Effect of Early vs Delayed Initiation of Adalimumab on Remission Rates in Patients With Crohn's Disease With Poor Prognostic Factors: The MODIFY Study.
Mantzaris GJ, Zeglinas C, Theodoropoulou A, Koutroubakis I, Orfanoudaki E, Katsanos K, Christodoulou D, Michalopoulos G, Tzouvala M, Moschovis D, Michopoulos S, Zampeli E, Soufleris K, Ilias A, Chatzievangelinou C, Kyriakakis A, Antachopoulou K, Karmiris K.
Mantzaris GJ, et al. Among authors: karmiris k.
Crohns Colitis 360. 2021 Sep 4;3(4):otab064. doi: 10.1093/crocol/otab064. eCollection 2021 Oct.
Crohns Colitis 360. 2021.
PMID: 36777275
Free PMC article.